Marvel Fusion Explores Laser Applications in Defense and Health Amid Fusion Commercialization Efforts

Marvel Fusion GmbH, a German nuclear fusion startup, is considering new applications for its laser technology in defense, health, and industry while facing challenges in commercializing fusion energy. The company is in discussions with investors and may relocate to the US for better access to capital. It aims to commercialize fusion by the mid-2030s, has raised $400 million, and is valued at approximately €1 billion. Marvel Fusion is also partnering with Colorado State University on a $150 million laser fusion research facility, with operations expected to start in early 2027.

Published Mar 26, 2026

Marvel Fusion GmbH is exploring new uses for its laser technology, including in defense and health sectors, as it struggles to commercialize nuclear fusion. The company is considering relocating to the US for improved capital access, though plans remain tentative.

AI-curated by Theia

Marvel aims to commercialize fusion by the mid-2030s, having raised $400 million and valued at around €1 billion. In partnership with Colorado State University, it is constructing a $150 million facility for laser fusion research, with operations delayed to early 2027. Additionally, Marvel secured a Department of Energy grant to support its US initiatives, while continuing its focus on laser-based fusion development.